The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

Rocket Pharmaceuticals received a regenerative medicine advanced therapy designation from the Food and Drug Administration for its heart disease treatment.

The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

Ozempic and Mounjaro drug makers are facing a lawsuit from a woman who says she had stomach paralysis as a side effect from the Type 2 diabetes drugs.

The drug was also well tolerated, with mostly mild or moderate gastrointestinal-related adverse events that Roche said were "consistent with the safety profile of the incretin drug class," and ...